|
Market Closed -
NYSE
16:00:00 2026-11-10 EST
|
5-day change | 1st Jan Change | ||
| 42.53 USD | -2.39% |
|
+0.14% | +62.39% |
Main features
| US46435U1925 | Fees | 0.47% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (CAD) | 341.1M | Replication Method | Direct (Physical) |
| Number of securities | 52 | AuM evolution | - | Date of creation | 2019-06-10 |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
CBOE
| IDNA | Real-time | |
NYSE
| IDNA | Delayed |
967021c0ff29d6481e1389ea06b65.3LRC7x2cJL33i5iFlcJ5FLhQ3-iirLc0ZhXOoZ6VfE0.lccdjlXdd-eR7e_wyoM-Q88JiJv388BzFkK68ev_Dwaa6xHXbMZI-5Pq6w
| Name |
Indicative Price |
Change |
Weight | |
|---|---|---|---|---|
| 57.08EUR | +0.81% | 4.51% | ||
| 6,593.00JPY | -1.20% | 4.37% | ||
| 916.06USD | -0.42% | 4.33% | ||
| 334.90CHF | -1.35% | 4.31% | ||
| 250.83USD | -6.75% | 4.29% | ||
| 148.05USD | -0.48% | 4.25% | ||
| 1,917.00GBX | +0.66% | 4.1% | ||
| 3,581.00DKK | -2.19% | 4.05% | ||
| 193.06USD | -3.54% | 4.03% | ||
| 547.89USD | -0.54% | 4.01% | ||
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | - |
| Theme and Sector | BioTech & Genomics |
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-10 | US$42.53 | -2.39% | 117,976 |
| 26-11-09 | US$43.57 | +2.98% | 252,461 |
| 26-11-06 | US$42.31 | +2.15% | 224,655 |
| 26-11-05 | US$41.42 | -6.18% | 293,397 |
| 26-11-04 | US$44.15 | +3.96% | 322,683 |
- Stock Market
- ETF
- IDNA ETF
Select your edition
All financial news and data tailored to specific country editions





















